Based on the study and your broader work on this issue, which I know you know a ton about this, what reforms do you recommend
The combined use of MNs with nanocarriers opens opportunities for synergy: microparticle carriers can target antigens to skin dendritic cells, while co-delivered immunomodulators (like cytokine-encapsulated liposomes) tune the immune response
Adaptive thermogenesis: your metabolism fights back This is the big one
Most manufacturers state that a pen must be discarded 56 days (eight weeks) after the first use, even if there is medication left
GLP-1 framing: The brand promotes GLPatch with the phrase "Reactivate Your GLP-1
GLP-1s are not recommended during pregnancy, but newer studies show they dont seem to increase the chance of developmental issues (2,7,13)